Aziyo Biologics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -4.38 | -100% |
| P/S |
|
1.17 | 33.58 | -96.52% |
|
|
| P/BV |
|
-11.42 | 4.79 | -338.29% |
|
|
| P/FCF |
|
-1.8 | 60.06 | -103% |
|
|
| Ev/Ebitda |
|
-3.37 | -17.26 | -80.49% |
|
|
| Ev/S |
|
1.53 | 22.49 | -93.18% |
|
|
| Ev/FCF |
|
-3.43 | 67.63 | -105.07% |
|
|
| E/P |
|
-0.8308 | 0.0168 | -5032.87% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-45.5 | 4.5 | -1111.91% | -34.17 | +33.15% |
| ROE |
|
-775.14 | 9.39 | -8353.8% |
|
|
| ROA |
|
-48.37 | 0.1519 | -31940.83% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-66.87 | -25.64 | 160.8% |
|
|
| ROCE |
|
-101.2 | 15.19 | -766.38% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-1.56 | -3.68 | -57.65% | -1.51 | +2.93% |
| Nеt Debt/Ebitda |
|
-0.7991 | -4.07 | -80.35% |
|
|
| Debt/Ratio |
|
0.5073 | 0.199 | 154.89% |
|
|
| Debt/Equity |
|
0.6884 | 1.67 | -58.66% |
|
|
| Debt/Net Income |
|
-1.06 | 10.34 | -110.26% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2331 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4916 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
3/10
|
18.18 | 76.2 | -76.14% | ||
| Growth impulse Ebitda in 5 years |
|
655.56 | 44.75 | 1364.94% | ||
| Growth impulse Net Income in 5 years |
|
174.79 | -15.36 | -1237.96% | ||
| Growth impulse FCF in 5 years |
|
155.13 | -9.39 | -1752.08% | ||
| Growth impulse EPS in 5 years |
|
11.54 | -84.03 | -113.73% |
IP Score
4.3/10
